These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 25925777)

  • 21. [A feature of hematological findings in myelodysplastic syndromes].
    Bando S; Niiya T; Murase M; Makino H
    Rinsho Byori; 1998 Aug; 46(8):790-5. PubMed ID: 9760831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estimating the prevalence of myelodysplastic syndromes in patients with unexplained cytopenias: a retrospective study of 322 bone marrows.
    Buckstein R; Jang K; Friedlich J; Zhang L; Reis M; Chesney A; Wells RA
    Leuk Res; 2009 Oct; 33(10):1313-8. PubMed ID: 19282029
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinico-haematological characteristics in Pakistani patients of primary myelodysplastic syndrome according to World Health Organization classification.
    Ehsan A; Aziz M
    J Coll Physicians Surg Pak; 2010 Apr; 20(4):232-6. PubMed ID: 20392397
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myelofibrosis in primary myelodysplastic syndromes: a retrospective study of 352 patients.
    Maschek H; Georgii A; Kaloutsi V; Werner M; Bandecar K; Kressel MG; Choritz H; Freund M; Hufnagl D
    Eur J Haematol; 1992 Apr; 48(4):208-14. PubMed ID: 1592101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Changes of natural kill cell in peripheral blood of patients with myelodysplastic syndrome].
    Mi H; Fu R; Wang H; Qu W; Ruan E; Wang X; Wang G; Liu H; Wu Y; Song J; Xing L; Guan J; Li L; Jiang H; Zhang W; Yue L; Shao Z
    Zhonghua Yi Xue Za Zhi; 2014 Mar; 94(10):737-41. PubMed ID: 24844955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [An analysis of prognostic factors in 80 myelodysplastic syndrome].
    Xu XQ; Wang JM; Lu SQ; Chen L; Yang JM; Zhang WP; Song XM; Xu YQ; Gong SL; Hou J; Ni X
    Zhonghua Xue Ye Xue Za Zhi; 2008 Nov; 29(11):723-7. PubMed ID: 19176004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence and prevalence of myelodysplastic syndromes: data from the Düsseldorf MDS-registry.
    Neukirchen J; Schoonen WM; Strupp C; Gattermann N; Aul C; Haas R; Germing U
    Leuk Res; 2011 Dec; 35(12):1591-6. PubMed ID: 21708407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Weekly standard doses of rh-EPO are highly effective for the treatment of anemic patients with low-intermediate 1 risk myelodysplastic syndromes.
    Balleari E; Clavio M; Arboscello E; Bellodi A; Bruzzone A; Del Corso L; Lucchetti MV; Miglino M; Passalia C; Pierri I; Ponassi I; Oneto C; Racchi O; Scudeletti M; Vignolo L; Zoppoli G; Gobbi M; Ghio R
    Leuk Res; 2011 Nov; 35(11):1472-6. PubMed ID: 21794914
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Analysis of in vitro characteristics of colony-forming cells in myelodysplastic syndrome and comparison with that in non-severe aplastic anemia].
    Zhang TJ; Feng M; Zheng YZ; Li XX; Xu ZF; Qin TJ; Zhang Y; Yang YB; Liu JX; Ren YS; Xiao ZJ
    Zhonghua Xue Ye Xue Za Zhi; 2012 Jul; 33(7):516-21. PubMed ID: 22967409
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary myelodysplastic syndromes: analysis of prognostic factors in 235 patients and proposals for an improved scoring system.
    Aul C; Gattermann N; Heyll A; Germing U; Derigs G; Schneider W
    Leukemia; 1992 Jan; 6(1):52-9. PubMed ID: 1736014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myelodysplastic syndromes in South America: a multinational study of 1080 patients.
    Belli CB; Pinheiro RF; Bestach Y; Larripa IB; da Silva Tanizawa RS; Alfonso G; Gonzalez J; Rosenhain M; Watman N; Cavalcante de Andrade Silva M; Negri Aranguren P; García Rivello H; Magalhaes SM; Valladares X; Undurraga MS; Velloso ER
    Am J Hematol; 2015 Oct; 90(10):851-8. PubMed ID: 26104573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predicting infections in high-risk patients with myelodysplastic syndrome/acute myeloid leukemia treated with azacitidine: a retrospective multicenter study.
    Merkel D; Filanovsky K; Gafter-Gvili A; Vidal L; Aviv A; Gatt ME; Silbershatz I; Herishanu Y; Arad A; Tadmor T; Dally N; Nemets A; Rouvio O; Ronson A; Herzog-Tzarfati K; Akria L; Braester A; Hellmann I; Yeganeh S; Nagler A; Leiba R; Mittelman M; Ofran Y
    Am J Hematol; 2013 Feb; 88(2):130-4. PubMed ID: 23345248
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myelodysplastic syndromes with monocytic component: hematologic and cytogenetic characterization.
    Rigolin GM; Cuneo A; Roberti MG; Bardi A; Castoldi G
    Haematologica; 1997; 82(1):25-30. PubMed ID: 9107078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Evolutive epidemiologic profile of myelodysplastic syndromes (1959-1993). Comparative study with acute myeloid leukemia and aplastic pancytopenias].
    Sánchez Fayos J; Outeiriño Pérez JJ; Prieto E; Román A; Olavarría E; Cabello A; Soto C; Calabuig T; Paniagua C; Sanz B
    Sangre (Barc); 1994 Dec; 39(6):441-8. PubMed ID: 7855696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Case-control study of risk factors of myelodysplastic syndromes according to World Health Organization classification in a Chinese population.
    Lv L; Lin G; Gao X; Wu C; Dai J; Yang Y; Zou H; Sun H; Gu M; Chen X; Fu H; Bao L
    Am J Hematol; 2011 Feb; 86(2):163-9. PubMed ID: 21264898
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survey of exposure to genotoxic agents in primary myelodysplastic syndrome: correlation with chromosome patterns and data on patients without hematological disease.
    Goldberg H; Lusk E; Moore J; Nowell PC; Besa EC
    Cancer Res; 1990 Nov; 50(21):6876-81. PubMed ID: 2208156
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recombinant human erythropoietin in very elderly patients with myelodysplastic syndromes: results from a retrospective study.
    Tatarelli C; Piccioni AL; Maurillo L; Naso V; Battistini R; D'Andrea M; Criscuolo M; Nobile C; Villivà N; Mancini S; Neri B; Breccia M; Fenu S; Buccisano F; Voso MT; Latagliata R; Aloe Spiriti MA
    Ann Hematol; 2014 Aug; 93(8):1413-20. PubMed ID: 24647684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The myelodysplastic syndrome and autoimmunity].
    Laursen SB; Nielsen MØ; Hasselbalch HC
    Ugeskr Laeger; 2009 Sep; 171(37):2639-42. PubMed ID: 19758507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trends in incidence, initial treatment and survival of myelodysplastic syndromes: a population-based study of 5144 patients diagnosed in the Netherlands from 2001 to 2010.
    Dinmohamed AG; Visser O; van Norden Y; Huijgens PC; Sonneveld P; van de Loosdrecht AA; Jongen-Lavrencic M
    Eur J Cancer; 2014 Mar; 50(5):1004-12. PubMed ID: 24388662
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The evaluation of the outcome in myelodysplastic patients by using non-cytogenetic prognostic scores.
    Căzăceanu O; Vlădăreanu A; Bumbea H; Begu M; Onisai M; Enache C
    J Med Life; 2014 Sep; 7(3):335-8. PubMed ID: 25408750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.